Treatment Regimen for Patients With ALK+ Non-Small Cell Lung Cancer
EP. 1: Case Presentation: Patient With ALK+ NSCLC
Watch
EP. 2: NSCLC: Initial Impressions and Alternate ALK Therapy
EP. 3: Typical Response, Progression, and Second-Line Therapy for NSCLC
EP. 4: Value of Repeat Mutation Testing for ALK+ NSCLC
EP. 5: ALK+ NSCLC: Brigatinib Indication and ALTA Trial
EP. 6: ALK+ NSCLC: PFS and Activity in CNS, Dosing, & Toxicity
EP. 7: Use of Brigatinib in ALK+ NSCLC & Future
